Not Yet Recruiting
Ustekinumab and Upadacitinib for Induction and Maintenance Therapy in Patients With Refractory Crohn's Disease: A Multicenter, Randomized, Parallel-Controlled Study
NCT07149467
- Conditions
- Crohn's Disease Aggravated, Crohn's Disease in Remission
- Locations
-
Not specified